Practice Management
Researchers found the oral antiviral drug nirmatrelvir/ritonavir (Paxlovid) is safe for kids as young as age 6 with mild/moderate COVID-19 who were at increased risk for severe disease, as published in Pediatrics. Of the in 75 children in the international study, 81% had 1 risk factor for severe COVID-19, most commonly obesity (49%) or chronic lung disease (40%). Additionally, 56% were unvaccinated. Children aged 6–17 years who weighed 40 kg or more received 300 mg …
Read More
A multi-state study analyzed prescribing patterns of influenza antiviral medications in emergency departments (ED) and urgent care (UC) centers and found that many high-risk adults (those with cardiovascular disease, renal disease, weakened immune systems, or individuals older than 70 years) with positive influenza virus test results do not receive antiviral treatment, which the authors believe could help reduce the risk of complications. As published in Clinical Infectious Diseases, researchers found that slightly more than half …
Read More